Innovative Focus X-BODY Biosciences specializes in discovering novel biotherapeutic compounds using an advanced, diverse DNA-tagged human antibody library, indicating potential interest in cutting-edge antibody discovery technologies.
Emerging Growth With recent funding of $2.7 million and revenue under one million dollars, the company is in a growth or development phase, presenting opportunities for strategic partnerships or pilot collaborations.
Therapeutic Targeting Focused on identifying human antibodies against new therapeutic targets, X-BODY is aligned with pharma and biotech firms seeking innovative drug discovery solutions, opening avenues for licensing or research collaborations.
Size & Scalability As a small company with 11-50 employees, X-BODY could benefit from scalable biotech solutions that support their expansion plans and enhance R&D productivity.
Industry Positioning Operating within a competitive landscape with similar-sized or larger peers, X-BODY presents opportunities for differentiation through advanced antibody libraries and specialized biotherapeutic discovery services.
$10M$25M
$50M$100M
$10M$25M
$100M$250M
$10M$25M
$25M$50M
$10M$25M
$50M$100M
$25M$50M| X-BODY Biosciences Email Formats | Percentage |
| First.Last@x-bodybiosciences.com | 25% |
| FLast@x-bodybiosciences.com | 25% |
| First.Last@x-bodybiosciences.com | 25% |
| FLast@x-bodybiosciences.com | 25% |
Biotechnology Research11-50 Employees
X-BODY is a privately held biotechnology company focused on discovering novel biotherapeutic compounds. The company’s mission is to apply its innovative capabilities and remarkably diverse DNA-tagged human antibody library to the discovery of human antibodies against novel therapeutic targets.
Company Overview
Funding & FinancialsX-BODY Biosciences has raised a total of $2.7M of funding over 2 rounds. Their latest funding round was raised on Feb 12, 2013 in the amount of $2.7M.
X-BODY Biosciences's revenue is estimated to be in the range of $1M
Funding & FinancialsX-BODY Biosciences has raised a total of $2.7M of funding over 2 rounds. Their latest funding round was raised on Feb 12, 2013 in the amount of $2.7M.
X-BODY Biosciences's revenue is estimated to be in the range of $1M
1-888-653-2347 
support@leadiq.com